INTERMEDIATES OF FINERENONE SIVELESTAT SODIUM

原料药和左旋肉碱的中间体

√Better chemical and mechanical stability than form I in

 Rezdiffra

√Bioequivalence consistency with Rezdiffra

√Lower hygroscopicity than form I in Rezdiffra, et al.

We're focused on R&D and production of API and pharm-intermediates. The products which protected by valid patents are for labs R&D purposes only and are not offered for sales in countries where the sales of such products constitutes a patent infringement。